European equities traded in the US as American depositary receipts were tracking sharply lower late Wednesday morning, falling 1.61% to 1,890.71 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet advertising firm Criteo (CRTO) and biotech company Evaxion (EVAX), which rose 3% and 2.9% respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and software firm SAP (SAP), which were up 2.6% and 2.4% respectively.

The decliners from continental Europe were led by telecommunications company Ericsson (ERIC) and pharmaceutical company Sanofi (SNY), which lost 2.6% and 2.3% respectively. They were followed by oil and gas company Eni (E) and brewing company Anheuser-Busch InBev (BUD), which fell 2.2% and 1.3% respectively.

The gainers from the UK were led by software firm Endava (DAVA) and biopharmaceutical company NuCana (NCNA), which advanced 5.7% and 3.3% respectively. They were followed by insurance company Prudential (PUK) and educational publisher Pearson (PSO), which increased 2.6% and 2.1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Trinity Biotech (TRIB), which fell 9.4% and 6.8% respectively. They were followed by pharmaceutical company AstraZeneca (AZN) and hospitality company InterContinental Hotels Group (IHG), which decreased 3% and 2.7% respectively.